Clinical Trial Update: Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the combination of omacetaxine and azacitidine in previously untreated patients with high-grade myelodysplastic syndromes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Omacetaxine (omacetaxine mepesuccinate)

Snippet

Sponsor: University of Colorado, Denver | Conditions: High Grade Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING